CSL Ltd
ASX:CSL
CSL Ltd
ASX:CSL
Price:
279.92 AUD
0.27%
Market Closed
Updated:
May 14, 2024
CSL Ltd
Interest Income Expense
|
CSL Ltd
Interest Income Expense Peer Comparison
Comparables:
IMM
OPT
MSB
CUV
TLX
Competitive Interest Income Expense Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Interest Income Expense | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
CSL Ltd
ASX:CSL
|
Interest Income Expense
-$469m
|
CAGR 3-Years
-38%
|
CAGR 5-Years
-27%
|
CAGR 10-Years
-25%
|
|
|
Immutep Ltd
ASX:IMM
|
Interest Income Expense
AU$2.8m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
14%
|
|
|
Opthea Ltd
ASX:OPT
|
Interest Income Expense
-$5.6m
|
CAGR 3-Years
16%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Mesoblast Ltd
ASX:MSB
|
Interest Income Expense
-$18.4m
|
CAGR 3-Years
-7%
|
CAGR 5-Years
-21%
|
CAGR 10-Years
N/A
|
|
|
Clinuvel Pharmaceuticals Ltd
ASX:CUV
|
Interest Income Expense
-AU$3.5m
|
CAGR 3-Years
-17%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-40%
|
|
|
Telix Pharmaceuticals Ltd
ASX:TLX
|
Interest Income Expense
-AU$733k
|
CAGR 3-Years
60%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is CSL Ltd's Interest Income Expense?
Interest Income Expense
-469m
USD
-469m
USD
Based on the financial report for Dec 31, 2023, CSL Ltd's Interest Income Expense amounts to -469m USD.
What is CSL Ltd's Interest Income Expense growth rate?
Interest Income Expense CAGR 10Y
-25%
-25%
Over the last year, the Interest Income Expense growth was -89%. The average annual Interest Income Expense growth rates for CSL Ltd have been -38% over the past three years , -27% over the past five years , and -25% over the past ten years .
You don't have any saved screeners yet
